Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: A cross-sectional study

Bone

Volumn 81, Issue , 2015, Pages 89-96

  Cools, M ^a   Goemaere, S ^a   Baetens, D ^a   Raes, A ^a   Desloovere, A ^a   Kaufman, J M ^a   De Schepper, J ^a   Jans, I ^b   Vanderschueren, D ^b   Billen, J ^b   De Baere, E ^a   Fiers, T ^a   Bouillon, R ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

CYP24A1; Heterozygous; Idiopathic infantile hypercalcemia; Mutation; Nephrocalcinosis; Nephrolithiasis

Indexed keywords

24,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL 24 HYDROXYLASE; PHOSPHATE; VITAMIN D; CYP24A1 PROTEIN, HUMAN; DIHYDROXYCOLECALCIFEROL;

ADULT; ARTICLE; BIOCHEMICAL ANALYSIS; BONE DENSITY; BONE HOMEOSTASIS; BONE MASS; CALCIUM HOMEOSTASIS; CALCIUM URINE LEVEL; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYP24A1 GENE; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; FEMALE; GENE MUTATION; GENOTYPING TECHNIQUE; HETEROZYGOTE; HOMEOSTASIS; HOMOZYGOTE; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; IDIOPATHIC INFANTILE HYPERCALCEMIA; KIDNEY CALCIFICATION; LIQUID CHROMATOGRAPHY; MALE; MIDDLE AGED; NEPHROLITHIASIS; PHOSPHATE BLOOD LEVEL; SANGER SEQUENCING; TANDEM MASS SPECTROMETRY; TERTIARY HEALTH CARE; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; WILD TYPE; YOUNG ADULT; BLOOD; BONE; GENETICS; GENOTYPE; INCIDENCE; METABOLISM; MUTATION; NEPHROCALCINOSIS; PEDIGREE; PHOTON ABSORPTIOMETRY;

ABSORPTIOMETRY, PHOTON; BONE AND BONES; CALCIUM; CHROMATOGRAPHY, LIQUID; CROSS-SECTIONAL STUDIES; DIHYDROXYCHOLECALCIFEROLS; FEMALE; GENOTYPE; HETEROZYGOTE; HOMEOSTASIS; HUMANS; HYPERCALCEMIA; HYPERCALCIURIA; INCIDENCE; MALE; MUTATION; NEPHROCALCINOSIS; NEPHROLITHIASIS; PEDIGREE; TANDEM MASS SPECTROMETRY; VITAMIN D3 24-HYDROXYLASE;

EID: 84969373534     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2015.06.018     Document Type: Article

References (37)

1. Smith D.W., Blizzard R.M., Harrison H.E. Idiopathic hypercalcemia; a case report with assays of vitamin D in the serum. Pediatrics 1959, 24:258-269.
2. Martin N.D., Snodgrass G.J., Cohen R.D. Idiopathic infantile hypercalcaemia-a continuing enigma. Arch. Dis. Child. 1984, 59:605-613.
3. Williams J.C., Barratt-Boyes B.G., Lowe J.B. Supravalvular aortic stenosis. Circulation 1961, 24:1311-1318.
4. Beuren A.J., Schulze C., Eberle P., Harmjanz D., Apitz J. The syndrome of supravalvular aortic stenosis, peripheral pulmonary stenosis, mental retardation and similar facial appearance. Am. J. Cardiol. 1964, 13:471-483.
5. Schlingmann K.P., Kaufmann M., Weber S., Irwin A., Goos C., John U., Misselwitz J., Klaus G., Kuwertz-Broking E., Fehrenbach H., Wingen A.M., Guran T., Hoenderop J.G., Bindels R.J., Prosser D.E., Jones G., Konrad M. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N. Engl. J. Med. 2011, 365:410-421.
6. Fencl F., Blahova K., Schlingmann K.P., Konrad M., Seeman T. Severe hypercalcemic crisis in an infant with idiopathic infantile hypercalcemia caused by mutation in CYP24A1 gene. Eur. J. Pediatr. 2013, 172:45-49.
7. Dauber A., Nguyen T.T., Sochett E., Cole D.E., Horst R., Abrams S.A., Carpenter TO, Hirschhorn J.N. Genetic defect in CYP24A1, the vitamin D 24-hydroxylase gene, in a patient with severe infantile hypercalcemia. J. Clin. Endocrinol. Metab. 2012, 97:E268-E274.
8. Tebben P.J., Milliner D.S., Horst R.L., Harris P.C., Singh R.J., Wu Y., Foreman J.W., Chelminski P.R., Kumar R. Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy. J. Clin. Endocrinol. Metab. 2012, 97:E423-E427.
9. Castanet M., Mallet E., Kottler M.L. Lightwood syndrome revisited with a novel mutation in CYP24 and vitamin D supplement recommendations. J. Pediatr. 2013, 163:1208-1210.
10. Kaufmann M., Gallagher J.C., Peacock M., Schlingmann K.P., Konrad M., DeLuca H.F., Sigueiro R., Lopez B., Mourino A., Maestro M., St-Arnaud R., Finkelstein J.S., Cooper D.P., Jones G. Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD. J. Clin. Endocrinol. Metab. 2014, 99:2567-2574.
11. Meusburger E., Mundlein A., Zitt E., Obermayer-Pietsch B., Kotzot D., Lhotta K. Medullary nephrocalcinosis in an adult patient with idiopathic infantile hypercalcaemia and a novel CYP24A1 mutation. Clin. Kidney J. 2013, 6:211-215.
12. Huang J., Coman D., McTaggart S.J., Burke J.R. Long-term follow-up of patients with idiopathic infantile hypercalcaemia. Pediatr. Nephrol. 2006, 21:1676-1680.
13. Dinour D., Beckerman P., Ganon L., Tordjman K., Eisenstein Z., Holtzman E.J. Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis. J. Urol. 2013, 190:552-557.
14. Wolf P., Muller-Sacherer T., Baumgartner-Parzer S., Winhofer Y., Kroo J., Gessl A., Luger A., Krebs M. A case of "late onset" idiopathic infantile hypercalcemia secondary to mutations in the CYP24A1 gene. Endocr. Pract. 2014, 1-14.
15. Jacobs T.P., Kaufman M., Jones G., Kumar R., Schlingmann K.P., Shapses S., Bilezikian J.P. A lifetime of hypercalcemia and hypercalciuria, finally explained. J. Clin. Endocrinol. Metab. 2014, 99:708-712.
16. Dowen F.E., Sayers J.A., Hynes A.M., Sayer J.A. CYP24A1 mutation leading to nephrocalcinosis. Kidney Int. 2014, 85:1475.
17. Jones G., Prosser D.E., Kaufmann M. 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Arch. Biochem. Biophys. 2012, 523:9-18.
18. Jones G., Prosser D.E., Kaufmann M. Cytochrome P450-mediated metabolism of vitamin D. J. Lipid Res. 2014, 55:13-31.
19. St-Arnaud R., Arabian A., Travers R., Barletta F., Raval-Pandya M., Chapin K., Depovere J., Mathieu C., Christakos S., Demay M.B., Glorieux F.H. Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology 2000, 141:2658-2666.
20. Bouillon R., Carmeliet G., Verlinden L., van Etten E., Verstuyf A., Luderer H.F., Lieben L., Mathieu C., Demay M. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 2008, 29:726-776.
21. Colussi G., Ganon L., Penco S., De Ferrari M.E., Ravera F., Querques M., Primignani P., Holtzman E.J., Dinour D. Chronic hypercalcaemia from inactivating mutations of vitamin D 24-hydroxylase (CYP24A1): implications for mineral metabolism changes in chronic renal failure. Nephrol. Dial. Transplant. 2014, 29:636-643.
22. Lieben L., Masuyama R., Torrekens S., Van Looveren R., Schrooten J., Baatsen P., Lafage-Proust M.H., Dresselaers T., Feng J.Q., Bonewald L.F., Meyer M.B., Pike J.W., Bouillon R., Carmeliet G. Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J. Clin. Invest. 2012, 122:1803-1815.
23. St-Arnaud R., Naja R.P. Vitamin D metabolism, cartilage and bone fracture repair. Mol. Cell. Endocrinol. 2011, 347:48-54.
24. Nesterova G., Malicdan M.C., Yasuda K., Sakaki T., Vilboux T., Ciccone C., Horst R., Huang Y., Golas G., Introne W., Huizing M., Adams D., Boerkoel C.F., Collins M.T., Gahl W.A. 1,25-(OH)2D-24 hydroxylase (CYP24A1) deficiency as a cause of nephrolithiasis. Clin. J. Am. Soc. Nephrol. 2013, 8:649-657.
25. Carpenter T.O. Take another CYP: confirming a novel mechanism for "idiopathic" hypercalcemia. J. Clin. Endocrinol. Metab. 2012, 97:768-771.
26. Sayers J., Hypponen E., Rice S.J., Hogg P., Sayers J.A. Searching for CYP24A1 mutations in cohorts of patients with calcium nephrolithiasis. OA Nephrol. 2013, 1:1-6.
27. Wang T.J., Zhang F., Richards J.B., Kestenbaum B., van Meurs J.B., Berry D., Kiel D.P., Streeten E.A., Ohlsson C., Koller D.L., Peltonen L., Cooper J.D., O'Reilly P.F., Houston D.K., Glazer N.L., Vandenput L., Peacock M., Shi J., Rivadeneira F., McCarthy M.I., Anneli P., de Boer I.H., Mangino M., Kato B., Smyth D.J., Booth S.L., Jacques P.F., Burke G.L., Goodarzi M., Cheung C.L., Wolf M., Rice K., Goltzman D., Hidiroglou N., Ladouceur M., Wareham N.J., Hocking L.J., Hart D., Arden N.K., Cooper C., Malik S., Fraser W.D., Hartikainen A.L., Zhai G., Macdonald H.M., Forouhi N.G., Loos R.J., Reid D.M., Hakim A., Dennison E., Liu Y., Power C., Stevens H.E., Jaana L., Vasan R.S., Soranzo N., Bojunga J., Psaty B.M., Lorentzon M., Foroud T., Harris T.B., Hofman A., Jansson J.O., Cauley J.A., Uitterlinden A.G., Gibson Q., Jarvelin M.R., Karasik D., Siscovick D.S., Econs M.J., Kritchevsky S.B., Florez J.C., Todd J.A., Dupuis J., Hypponen E., Spector T.D. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010, 376:180-188.
28. O'Seaghdha C.M., Wu H., Yang Q., Kapur K., Guessous I., Zuber A.M., Kottgen A., Stoudmann C., Teumer A., Kutalik Z., Mangino M., Dehghan A., Zhang W., Eiriksdottir G., Li G., Tanaka T., Portas L., Lopez L.M., Hayward C., Lohman K., Matsuda K., Padmanabhan S., Firsov D., Sorice R., Ulivi S., Brockhaus A.C., Kleber M.E., Mahajan A., Ernst F.D., Gudnason V., Launer L.J., Mace A., Boerwinckle E., Arking D.E., Tanikawa C., Nakamura Y., Brown M.J., Gaspoz J.M., Theler J.M., Siscovick D.S., Psaty B.M., Bergmann S., Vollenweider P., Vitart V., Wright A.F., Zemunik T., Boban M., Kolcic I., Navarro P., Brown E.M., Estrada K., Ding J., Harris T.B., Bandinelli S., Hernandez D., Singleton A.B., Girotto G., Ruggiero D., d'Adamo A.P., Robino A., Meitinger T., Meisinger C., Davies G., Starr J.M., Chambers J.C., Boehm B.O., Winkelmann B.R., Huang J., Murgia F., Wild S.H., Campbell H., Morris A.P., Franco O.H., Hofman A., Uitterlinden A.G., Rivadeneira F., Volker U., Hannemann A., Biffar R., Hoffmann W., Shin S.Y., Lescuyer P., Henry H., Schurmann C., Consortium S., Consortium G., Munroe P.B., Gasparini P., Pirastu N., Ciullo M., Gieger C., Marz W., Lind L., Spector T.D., Smith A.V., Rudan I., Wilson J.F., Polasek O., Deary I.J., Pirastu M., Ferrucci L., Liu Y., Kestenbaum B., Kooner J.S., Witteman J.C., Nauck M., Kao W.H., Wallaschofski H., Bonny O., Fox C.S., Bochud M. Meta-analysis of genome-wide association studies identifies six new loci for serum calcium concentrations. PLoS Genet. 2013, 9:e1003796.
29. Casetta B., Jans I., Billen J., Vanderschueren D., Bouillon R. Development of a method for the quantification of 1alpha,25(OH)2-vitamin D3 in serum by liquid chromatography tandem mass spectrometry without derivatization. Eur. J. Mass Spectrom. (Chichester, Eng.) 2010, 16:81-89.
30. Vanderschueren D., Pye S.R., O'Neill T.W., Lee D.M., Jans I., Billen J., Gielen E., Laurent M., Claessens F., Adams J.E., Ward K.A., Bartfai G., Casanueva F.F., Finn J.D., Forti G., Giwercman A., Han T.S., Huhtaniemi I.T., Kula K., Lean M.E., Pendleton N., Punab M., Wu F.C., Boonen S., Group ES Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: the European Male Aging Study (EMAS). J. Clin. Endocrinol. Metab. 2013, 98:995-1005.
31. Baecke J.A., Burema J., Frijters J.E. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am. J. Clin. Nutr. 1982, 36:936-942.
32. Spiro A., Buttriss J.L. Vitamin D: an overview of vitamin D status and intake in Europe. Nutr. Bull. Br. Nutr. Found. 2014, 1-29.
33. Hilger J., Friedel A., Herr R., Rausch T., Roos F., Wahl D.A., Pierroz D.D., Weber P., Hoffmann K. A systematic review of vitamin D status in populations worldwide. Br. J. Nutr. 2014, 111:23-45.
34. Dinour D., Davidovits M., Aviner S., Ganon L., Michael L., Modan-Moses D., Vered I., Bibi H., Frishberg Y., Holtzman E.J. Maternal and infantile hypercalcemia caused by vitamin-D-hydroxylase mutations and vitamin D intake. Pediatr. Nephrol. 2015, 30:145-152.
35. Dufek S., Seidl R., Schmook M., Arbeiter K., Muller-Sacherer T., Heindl-Rusai K. Intracranial hypertension in siblings with infantile hypercalcemia. Neuropediatrics 2015, 46:49-51.
36. Samuel H.S. Infantile hypercalcaemia, nutritional rickets, and infantile scurvy in Great Britain. A British Paediatric Association report. Br. Med. J. 1964, 1:1659-1661.
37. Figueres M.L., Linglart A., Bienaime F., Allain-Launay E., Roussey-Kessler G., Ryckewaert A., Kottler M.L., Hourmant M. Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations. Am. J. Kidney Dis. 2015, 65:122-126.